“湘”当能“械” 体制创新驱动 湘潭医疗器械产业蝶变
Zhong Guo Zheng Quan Bao·2025-11-23 20:15

Core Insights - Hunan Xiangtan is transforming from a traditional Chinese medicine distribution center to a leading hub for medical device innovation in China, with a projected total output value exceeding 13 billion yuan by 2024 [1] Group 1: Industry Development - The Hunan Medical Device Industrial Park has been recognized as a national benchmark for medical device industrial parks for two consecutive years, showcasing effective integration of technological and industrial innovation [1] - The park has established a unique "4+N" service system that integrates government support with market efficiency, addressing common industry challenges such as slow approval processes and intellectual property conversion difficulties [2] Group 2: Approval Process Innovation - The establishment of the Hunan Provincial Drug Supervision Administration's Xiangtan branch has significantly improved the efficiency of product registration and approval, allowing companies to bring products to market faster [2] - For instance, Hunan Deps Medical Technology Co., Ltd. received its registration certificate in just one month, compared to the typical six-month timeframe for medical device production licenses [2] Group 3: Corporate Innovation - The Hunan Medical Device Industrial Park has developed a comprehensive industrial ecosystem that supports companies through all stages, from concept validation to clinical trials and logistics [3] - Companies like Huaxin Medical are gaining a foothold in the global market, with their products being exported to over 160 countries, demonstrating the park's capacity for fostering innovation [3] Group 4: Ecosystem and Cluster Development - The industrial park has cultivated a diverse ecosystem, with 55 national high-tech enterprises and 6 national specialized "little giant" companies, indicating a robust industrial cluster [4] - By October 2025, the park is expected to host over 290 enterprises, with a focus on medical devices, consumables, in vitro diagnostics, medical aesthetics, and software [5]